The DOI matches its Crossref record.
Plasma leptin and colorectal cancer risk: A prospective study in Northern Sweden
Abstract
Obesity is associated with an increased risk of colorectal cancer. Circulating levels of leptin are high in obesity and strongly correlated to levels of insulin. Leptin stimulates growth of colon cancer cells. In a nested case-control study, we measured leptin levels in prediagnostic plasma from 75 men and 93 women who were diagnosed with colorectal cancer mean time 3.4 years (SD 2.4) after recruitment and among 327 control subjects. Logistic regression analyses showed increases in colorectal cancer risk in men with increasing levels of leptin, odds ratios (OR) were 1.00 (ref), 0.85 (95% C.I.=0.33-2.23), 1.04 (0.43-2.53), and 2.15 (0.89-5.22), (pfor trend=0.08). There was a distinct threshold between the third and fourth quartile of leptin, and the odds ratio for top quartile vs. three bottom quartiles was 2.28 (1.09-4.76). Adjustment for body mass index and insulin did not affect risk estimates. In separate analysis, odds ratio for top vs. bottom tertile of colon cancer was 1.96 (95% C.I.=0.72-5.29), whereas no increase was seen for rectal cancer. In women, no association between leptin and risk was seen. These data support the hypothesis that leptin is a risk marker for colorectal cancer in men, but not in women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bardou, M., Barkun, A. N., & Martel, M. (2013) · Gut · doi:10.1136/gutjnl-2013-304701 · Cited by 815
Obesity and cancer: the role of dysfunctional adipose tissue
van Kruijsdijk, R. C. M., van der Wall, E., & Visseren, F. L. J. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0372 · Cited by 715
Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies
Larsson, S. C., & Wolk, A. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.556 · Cited by 632
Obesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies
Ma, Y., Yang, Y., Wang, F., Zhang, P., Shi, C., Zou, Y., & Qin, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053916 · Cited by 622
Garofalo, C., & Surmacz, E. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20472 · Cited by 588
Pischon, T., Lahmann, P. H., Boeing, H., Friedenreich, C., Norat, T., Tjønneland, A., Halkjaer, J., Overvad, K., Clavel-Chapelon, F., Boutron-Ruault, M.-C., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj246 · Cited by 554
Self-citationGiovannucci, E., & Michaud, D. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.050 · Cited by 543
Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes
Baidoun, F., Elshiwy, K., Elkeraie, Y., Merjaneh, Z., Khoudari, G., Sarmini, M. T., Gad, M., Al-Husseini, M., & Saad, A. (2021) · Current Drug Targets · doi:10.2174/1389450121999201117115717 · Cited by 523
Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression
Vona-Davis, L., & Rose, D. P. (2007) · Endocrine-Related Cancer · doi:10.1677/erc-06-0068 · Cited by 496
Serum protein markers for early detection of ovarian cancer
Mor, G., Visintin, I., Lai, Y., Zhao, H., Schwartz, P., Rutherford, T., Yue, L., Bray-Ward, P., & Ward, D. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502178102 · Cited by 482
Obesity and cancer: inflammation bridges the two
Kolb, R., Sutterwala, F. S., & Zhang, W. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.07.005 · Cited by 405
Obesity and cancer: Pathophysiological and biological mechanisms
Renehan, A. G., Roberts, D. L., & Dive, C. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801954303 · Cited by 402
Influence of obesity on the risk of developing colon cancer
Frezza, E. E., Wachtel, M. S., & Chiriva-Internati, M. (2006) · Gut · doi:10.1136/gut.2005.073163 · Cited by 345
Body Mass Index and Outcomes in Patients Who Receive Adjuvant Chemotherapy for Colon Cancer
Dignam, J. J., Polite, B. N., Yothers, G., Raich, P., Colangelo, L., O'Connell, M. J., & Wolmark, N. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj442 · Cited by 325
Obesity and cancer: Symposium on ‘Diet and cancer’
Pischon, T., Nöthlings, U., & Boeing, H. (2008) · Proceedings of the Nutrition Society · doi:10.1017/s0029665108006976 · Cited by 320
Obesity and colon cancer: Does leptin provide a link?
Stattin, P., Lukanova, A., Biessy, C., Söderberg, S., Palmqvist, R., Kaaks, R., Olsson, T., & Jellum, E. (2004) · International Journal of Cancer · doi:10.1002/ijc.11668 · Cited by 319
Self-citationBMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults
Moore, L. L., Bradlee, M. L., Singer, M. R., Splansky, G. L., Proctor, M. H., Ellison, R. C., & Kreger, B. E. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802606 · Cited by 315
Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes
Gunter, M. J., & Leitzmann, M. F. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.06.011 · Cited by 310
The growing challenge of obesity and cancer: an inflammatory issue
Harvey, A. E., Lashinger, L. M., & Hursting, S. D. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06096.x · Cited by 272
Metadata
- Authors
- Stattin, P., Palmqvist, R., Söderberg, S., Biessy, C., Ardnor, B., Hallmans, G., Kaaks, R., & Olsson, T.
- Venue
- Oncology Reports
- Publisher
- Spandidos Publications
- Published
- 2003-11-01
- Volume
- 10
- Issue
- 6
- Pages
- 2015-21
- ISSN
- 1021-335X (ISSN-L)
- 1791-2431
- OpenAlex
- W1967563637
- Cited by
- 178
- References
- 0
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.